An investigation using triple transgenic AD model mice carrying PS1 (M146V), APP (Swe), and tau (P301L) transgenes showed that between 3 and 15 months of age, all three activities of the proteasome decreased in the brains of these mice. This evidence concerns the gene APP and Alzheimer disease.